Cavium (CAVM) Expected to Announce Quarterly Sales of $259.99 Million

Equities analysts forecast that Cavium (NASDAQ:CAVM) will announce sales of $259.99 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Cavium’s earnings. The highest sales estimate is $265.00 million and the lowest is $255.00 million. Cavium reported sales of $229.58 million during the same quarter last year, which indicates a positive year over year growth rate of 13.2%. The company is scheduled to report its next quarterly earnings results on Wednesday, April 25th.

On average, analysts expect that Cavium will report full-year sales of $1.11 billion for the current financial year, with estimates ranging from $1.09 billion to $1.13 billion. For the next fiscal year, analysts anticipate that the business will post sales of $1.26 billion per share, with estimates ranging from $1.22 billion to $1.30 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Cavium.

Cavium (NASDAQ:CAVM) last announced its quarterly earnings results on Wednesday, January 31st. The semiconductor provider reported $0.83 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.02. Cavium had a negative net margin of 7.00% and a positive return on equity of 14.07%. The firm had revenue of $260.36 million for the quarter, compared to analyst estimates of $260.05 million. During the same quarter in the previous year, the firm posted $0.56 earnings per share. The business’s revenue was up 15.1% on a year-over-year basis.

A number of research analysts have weighed in on the stock. Zacks Investment Research raised shares of Cavium from a “sell” rating to a “hold” rating in a research note on Tuesday, January 23rd. Stifel Nicolaus lifted their price target on shares of Cavium from $68.00 to $81.00 and gave the company a “hold” rating in a research note on Thursday, February 1st. Raymond James lowered shares of Cavium from an “outperform” rating to a “market perform” rating and set a $80.00 price target on the stock. in a research note on Friday, February 2nd. ValuEngine lowered shares of Cavium from a “hold” rating to a “sell” rating in a research note on Thursday. Finally, BidaskClub lowered shares of Cavium from a “hold” rating to a “sell” rating in a research note on Wednesday, April 4th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $79.33.

CAVM traded down $1.47 during trading on Friday, reaching $77.13. The company had a trading volume of 609,459 shares, compared to its average volume of 816,980. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.26 and a current ratio of 2.80. Cavium has a 12 month low of $56.96 and a 12 month high of $92.66. The firm has a market cap of $5,490.13, a P/E ratio of 964.13, a PEG ratio of 1.97 and a beta of 1.34.

In related news, Director Sanjay Mehrotra sold 12,500 shares of the business’s stock in a transaction on Friday, March 9th. The shares were sold at an average price of $91.20, for a total transaction of $1,140,000.00. Following the transaction, the director now directly owns 85,511 shares in the company, valued at $7,798,603.20. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Vincent P. Pangrazio sold 8,000 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $87.19, for a total transaction of $697,520.00. Following the transaction, the senior vice president now owns 54,577 shares in the company, valued at $4,758,568.63. The disclosure for this sale can be found here. In the last three months, insiders sold 353,962 shares of company stock worth $31,361,100. 4.65% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of CAVM. Deutsche Bank AG increased its holdings in Cavium by 194.7% during the fourth quarter. Deutsche Bank AG now owns 1,278,438 shares of the semiconductor provider’s stock worth $107,168,000 after buying an additional 844,622 shares during the last quarter. Alpine Associates Management Inc. acquired a new position in Cavium during the fourth quarter worth $69,825,000. Carillon Tower Advisers Inc. acquired a new position in Cavium during the fourth quarter worth $36,031,000. Omni Partners LLP acquired a new position in Cavium during the fourth quarter worth $30,098,000. Finally, Alliancebernstein L.P. increased its holdings in Cavium by 130.7% during the fourth quarter. Alliancebernstein L.P. now owns 484,307 shares of the semiconductor provider’s stock worth $40,599,000 after buying an additional 274,390 shares during the last quarter. Institutional investors and hedge funds own 92.11% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3377941/cavium-cavm-expected-to-announce-quarterly-sales-of-259-99-million.html.

Cavium Company Profile

Cavium, Inc designs, develops, and markets semiconductor processors for intelligent and secure networks in the United States and internationally. The company offers integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage, and security applications.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Critical Analysis: Intercontinental Exchange  & BGC Partners
Critical Analysis: Intercontinental Exchange & BGC Partners
Glen Harbor Capital Management LLC Purchases 91,308 Shares of Owens-Illinois Inc
Glen Harbor Capital Management LLC Purchases 91,308 Shares of Owens-Illinois Inc
Glen Harbor Capital Management LLC Sells 3,080 Shares of Mettler-Toledo International Inc.
Glen Harbor Capital Management LLC Sells 3,080 Shares of Mettler-Toledo International Inc.
Acorn Energy  & VSE  Critical Analysis
Acorn Energy & VSE Critical Analysis
Pure Storage  and Seagate Technology  Critical Contrast
Pure Storage and Seagate Technology Critical Contrast
Envestnet Asset Management Inc. Has $4.14 Million Position in Arch Capital Group
Envestnet Asset Management Inc. Has $4.14 Million Position in Arch Capital Group


© 2006-2018 Ticker Report. Google+.